T Cell News and Research

Latest T Cell News and Research

JHUSON introduces Text4Baby program to provide parenting tips to new parents

Having a baby is a very exciting time for new parents, with all the preparation and anticipation that comes with it. But how do parents find help and assistance—from prenatal care to parenting tips? Researchers at the Johns Hopkins University School of Nursing have come up with innovative ways to provide parenting tips to new parents of all demographics.

24 Apr 2010

Mechanisms pathogenic viruses exploit to evade immune systems of hosts

Viruses have evolved a broad range of strategies that enable them to evade the immune systems of their hosts. A team of researchers led by LMU virologist Professor J-rgen Haas has been studying a novel, recently discovered mechanism that pathogenic viruses exploit for this purpose, and their latest results could point the way to new antiviral therapies. The mechanism is based on the production of short RNA molecules, called microRNAs, by the virus.

24 Apr 2010

Novel clinical research approaches for rapidly identifying and preventing congenital cardiovascular defects

Structural and functional congenital cardiovascular abnormalities present at birth are the leading source of all congenital defects encountered in live births. Nearly half a million children in the United States have structural heart problems ranging in severity from relatively simple issues, such as small holes between chambers of the heart, to very severe malformations, including complete absence of one or more chambers or valves.

24 Apr 2010

Myths and facts about pediatric cancer

"Your child has cancer." They are words every parent can't imagine hearing.

24 Apr 2010

Programs to address care for children born with SCD during adulthood

Forty years ago, children born with sickle cell disease (SCD) were not expected to live past their teenage years. Today, medical advances are allowing children to live well into adulthood, raising concerns over who is going to care for these patients as adults. However, programs are underway to address these concerns, as reported in the March/April edition of Journal of Pediatric Oncology Nursing, published by the Association of Pediatric Hematology/Oncology Nurses (APHON).

24 Apr 2010

Current concepts and recent research findings on gene therapy for inner ear disorders

Gene therapy holds great potential for the treatment not only of genetic disorders, but also of many acquired diseases. This is as true for the inner ear as for any other organ. However, the technical challenges that must be overcome before gene therapy becomes more widely used are remarkable. In the inner ear the size, accessibility, delicacy and the involvement of many different cell types present unique conditions.

24 Apr 2010

Animal studies demonstrate safety profile of ACT's RPE cell therapy for SMD

Advanced Cell Technology, Inc. announced today that it has completed key animal studies in connection with its Phase I multicenter study using embryonic stem cell derived Retinal Pigment Epithelium (RPE) cells to treat patients with Stargardt's Macular Dystrophy (SMD), for which it filed an Investigational New Drug Application (IND) with the US Food and Drug Administration (FDA) in November. The studies demonstrated an excellent safety profile with no safety signals such as tumors or ectopic tissues.

24 Apr 2010

AlloMap molecular expression test reduces need for invasive heart-muscle biopsies

Monitoring rejection in heart transplantation patients with a simple blood test co-developed by NewYork-Presbyterian Hospital/Columbia University Medical Center physician-scientist Dr. Mario Deng in 2005 can safely reduce their need for invasive heart-muscle biopsies, a new study has found.

24 Apr 2010

McGill researchers receive $1.7M for 10 cutting-edge research projects

Ten McGill University researchers received an important boost today, by way of the announcement of $1.7 million in new funding awarded through the Canada Foundation for Innovation's Leaders Opportunity Fund. "CFI investments are critical for our research leaders, to ensure that their research remains innovative and second to none," said Dr. Rima Rozen, Interim Vice-Principal (Research and International Relations) at McGill.

24 Apr 2010

Moffitt Cancer Center reports increasing interest in ERCC1 Analysis test for selecting chemotherapy for NSCLC

Moffitt Cancer Center announces steadily growing interest in the ERCC1 Analysis, the first test developed for selecting chemotherapy for Non Small Lung Cancer patients. Each year, more than 200,000 Americans are diagnosed with lung cancer.

24 Apr 2010

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

Cardiola AG announced today that the Company's CE-Marked m.pulse® Muscular CounterPulsation ("MCP")-based system demonstrated "an immediate improvement of cardiac output with non-invasive means" in a patient population of advanced yet stable chronic heart failure. The effects could be shown in 22 patients over three consecutive days.

24 Apr 2010

Environmental factors may play bigger role in tumor development: BIDMC study

It is an accepted fact that genetics play a key role in a person's susceptibility to cancer, and that throughout life, mutations can cause damage to tumor suppressor genes further increasing the chances of developing cancerous tumors.

24 Apr 2010

Merz Aesthetics debuts at ASAPS annual meeting with announcement of FDA approval of Asclera Injection

Following news of the acquisition of BioForm Medical, Inc. earlier this year, Merz Aesthetics, the new business unit of Merz Pharma Group, makes its debut at the prestigious American Society of Aesthetic Plastic Surgeons (ASAPS) annual meeting with the announcement of the U.S. Food and Drug Administration's (FDA) recent approval of Asclera™ (polidocanol) Injection, a sclerotherapy treatment for uncomplicated spider and reticular veins.

24 Apr 2010

IDEXX Laboratories' first-quarter 2010 revenues increase 14% to $268.5M

IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.

23 Apr 2010

State of California adds Distracted Driving as new area for concentrated effort to SHSP

Driver distractions have joined alcohol and speeding as leading factors in fatal and serious injury crashes. The National Safety Council estimates that up to 25 percent of all crashes in 2008 involved talking on cell phones or texting. To combat this growing threat on our roadways, the State of California has added Distracted Driving as the first new area for concentrated effort to the Strategic Highway Safety Plan.

23 Apr 2010

Team liberates cellular hostages by silencing Toxoplasma gondii's back-seat driving

Scientists studying a cunning parasite that has commandeered the cells of almost half the world's human population have begun to zero in on the molecular signals that must be severed to free the organism's cellular hostages.

23 Apr 2010

Research into Planarian worm 'Smed-prep' gene may pave way for regeneration of human organs

Scientists at The University of Nottingham have discovered the gene that enables an extraordinary worm to regenerate its own body parts after amputation — including a whole head and brain.

23 Apr 2010

Crystal structures of key fluorescent proteins to "light up" molecules in cells

Scientists at Albert Einstein College of Medicine of Yeshiva University have determined the crystal structures of two key fluorescent proteins - one blue, one red - used to "light up" molecules in cells.

23 Apr 2010

Advances in understanding of cardiac-specific genes in heart development

Researchers at the Texas Heart Institute at St. Luke's Episcopal Hospital (THI at St. Luke's) announced today the results of research which they believe marks a significant advance in understanding how cardiac-specific genes are turned on during the development of the heart in mice embryos.

23 Apr 2010

University of Granada scientists create artificial human skin with dermis made of fibrin-agarose biomaterial

Scientists from the University of Granada, Spain, have generated artificial human skin by tissular engineering basing on agarose-fibrin biomaterial. The artificial skin was grafted onto mice, and optimal development, maturation and functionality results were obtained.

23 Apr 2010

T Cell News and Research

Latest T Cell News and Research

JHUSON introduces Text4Baby program to provide parenting tips to new parents

Mechanisms pathogenic viruses exploit to evade immune systems of hosts

Novel clinical research approaches for rapidly identifying and preventing congenital cardiovascular defects

Myths and facts about pediatric cancer

Programs to address care for children born with SCD during adulthood

Current concepts and recent research findings on gene therapy for inner ear disorders

Animal studies demonstrate safety profile of ACT's RPE cell therapy for SMD

AlloMap molecular expression test reduces need for invasive heart-muscle biopsies

McGill researchers receive $1.7M for 10 cutting-edge research projects

Moffitt Cancer Center reports increasing interest in ERCC1 Analysis test for selecting chemotherapy for NSCLC

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

Environmental factors may play bigger role in tumor development: BIDMC study

Merz Aesthetics debuts at ASAPS annual meeting with announcement of FDA approval of Asclera Injection

IDEXX Laboratories' first-quarter 2010 revenues increase 14% to $268.5M

State of California adds Distracted Driving as new area for concentrated effort to SHSP

Team liberates cellular hostages by silencing Toxoplasma gondii's back-seat driving

Research into Planarian worm 'Smed-prep' gene may pave way for regeneration of human organs

Crystal structures of key fluorescent proteins to "light up" molecules in cells

Advances in understanding of cardiac-specific genes in heart development

University of Granada scientists create artificial human skin with dermis made of fibrin-agarose biomaterial

Immunology eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Newsletters you may be interested in